Form 8-K - Current report:
SEC Accession No. 0001193125-20-317074
Filing Date
2020-12-14
Accepted
2020-12-14 17:01:02
Documents
15
Period of Report
2020-12-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d36307d8k.htm   iXBRL 8-K 30614
2 EX-3.1 d36307dex31.htm EX-3.1 8912
3 EX-3.2 d36307dex32.htm EX-3.2 46729
  Complete submission text file 0001193125-20-317074.txt   267566

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pfe-20201214.xsd EX-101.SCH 4525
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20201214_def.xml EX-101.DEF 14120
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20201214_lab.xml EX-101.LAB 23469
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20201214_pre.xml EX-101.PRE 15153
8 EXTRACTED XBRL INSTANCE DOCUMENT d36307d8k_htm.xml XML 6466
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 201386906
SIC: 2834 Pharmaceutical Preparations